Literature DB >> 18955168

XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Sikandar G Khan1, Kyu-Seon Oh, Steffen Emmert, Kyoko Imoto, Deborah Tamura, John J Digiovanna, Tala Shahlavi, Najealicka Armstrong, Carl C Baker, Marcy Neuburg, Chris Zalewski, Carmen Brewer, Edythe Wiggs, Raphael Schiffmann, Kenneth H Kraemer.   

Abstract

Two unrelated xeroderma pigmentosum (XP) patients, with and without neurological abnormalities, respectively, had identical defects in the XPC DNA nucleotide excision repair (NER) gene. Patient XP21BE, a 27-year-old woman, had developmental delay and early onset of sensorineural hearing loss. In contrast, patient XP329BE, a 13-year-old boy, had a normal neurological examination. Both patients had marked lentiginous hyperpigmentation and multiple skin cancers at an early age. Their cultured fibroblasts showed similar hypersensitivity to killing by UV and reduced repair of DNA photoproducts. Cells from both patients had a homozygous c.2T>G mutation in the XPC gene which changed the ATG initiation codon to arginine (AGG). Both had low levels of XPC message and no detectable XPC protein on Western blotting. There was no functional XPC activity in both as revealed by the failure of localization of XPC and other NER proteins at the sites of UV-induced DNA damage in a sensitive in vivo immunofluorescence assay. XPC cDNA containing the initiation codon mutation was functionally inactive in a post-UV host cell reactivation (HCR) assay. Microsatellite markers flanking the XPC gene showed only a small region of identity ( approximately 30kBP), indicating that the patients were not closely related. Thus, the initiation codon mutation resulted in DNA repair deficiency in cells from both patients and greatly increased cancer susceptibility. The neurological abnormalities in patient XP21BE may be related to close consanguinity and simultaneous inheritance of other recessive genes or other gene modifying effects rather than the influence of XPC gene itself.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955168      PMCID: PMC2684809          DOI: 10.1016/j.dnarep.2008.09.007

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  42 in total

1.  Sequential assembly of the nucleotide excision repair factors in vivo.

Authors:  M Volker; M J Moné; P Karmakar; A van Hoffen; W Schul; W Vermeulen; J H Hoeijmakers; R van Driel; A A van Zeeland; L H Mullenders
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

Review 2.  Xeroderma pigmentosum--bridging a gap between clinic and laboratory.

Authors:  S Moriwaki; K H Kraemer
Journal:  Photodermatol Photoimmunol Photomed       Date:  2001-04       Impact factor: 3.135

Review 3.  Quantitation and visualization of ultraviolet-induced DNA damage using specific antibodies: application to pigment cell biology.

Authors:  N Kobayashi; S Katsumi; K Imoto; A Nakagawa; S Miyagawa; M Furumura; T Mori
Journal:  Pigment Cell Res       Date:  2001-04

Review 4.  Cockayne syndrome and xeroderma pigmentosum.

Authors:  I Rapin; Y Lindenbaum; D W Dickson; K H Kraemer; J H Robbins
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

5.  A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.

Authors:  E M Gozukara; S G Khan; A Metin; S Emmert; D B Busch; T Shahlavi; D M Coleman; M Miller; N Chinsomboon; M Stefanini; K H Kraemer
Journal:  J Invest Dermatol       Date:  2001-08       Impact factor: 8.551

6.  Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.

Authors:  H Slor; S Batko; S G Khan; T Sobe; S Emmert; A Khadavi; A Frumkin; D B Busch; R B Albert; K H Kraemer
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

7.  Hypoglycinaemia and psychomotor delay in a child with xeroderma pigmentosum.

Authors:  E J Quackenbush; K H Kraemer; W A Gahl; V Schirch; D A Whiteman; K Levine; H L Levy
Journal:  J Inherit Metab Dis       Date:  1999-12       Impact factor: 4.982

8.  Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.

Authors:  F Chavanne; B C Broughton; D Pietra; T Nardo; A Browitt; A R Lehmann; M Stefanini
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

9.  Xeroderma pigmentosum exhibiting neurological disorders and systemic lupus erythematosus.

Authors:  J Hananian; J E Cleaver
Journal:  Clin Genet       Date:  1980-01       Impact factor: 4.438

10.  Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.

Authors:  Steffen Emmert; Hanoch Slor; David B Busch; Sima Batko; Roberta B Albert; Donna Coleman; Sikandar G Khan; Bassam Abu-Libdeh; John J DiGiovanna; Bari B Cunningham; Myung-Moo Lee; Jill Crollick; Hiroki Inui; Takahiro Ueda; Mohammad Hedayati; Lawrence Grossman; Tala Shahlavi; James E Cleaver; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2002-06       Impact factor: 8.551

View more
  16 in total

1.  Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells.

Authors:  Emilie Warrick; Marta Garcia; Corinne Chagnoleau; Odile Chevallier; Valérie Bergoglio; Daniela Sartori; Fulvio Mavilio; Jaime F Angulo; Marie-Françoise Avril; Alain Sarasin; Fernando Larcher; Marcela Del Rio; Françoise Bernerd; Thierry Magnaldo
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

2.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 3.  Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.

Authors:  James E Cleaver; Ernest T Lam; Ingrid Revet
Journal:  Nat Rev Genet       Date:  2009-10-07       Impact factor: 53.242

Review 4.  Oxidative DNA damage and nucleotide excision repair.

Authors:  Joost P M Melis; Harry van Steeg; Mirjam Luijten
Journal:  Antioxid Redox Signal       Date:  2012-12-07       Impact factor: 8.401

Review 5.  Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders.

Authors:  Mohsen Hosseini; Khaled Ezzedine; Alain Taieb; Hamid R Rezvani
Journal:  J Invest Dermatol       Date:  2014-10-09       Impact factor: 8.551

6.  Founder mutations in xeroderma pigmentosum.

Authors:  Deborah Tamura; John J DiGiovanna; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2010-06       Impact factor: 8.551

7.  Nucleotide excision repair proteins rapidly accumulate but fail to persist in human XP-E (DDB2 mutant) cells.

Authors:  Kyu-Seon Oh; Kyoko Imoto; Steffen Emmert; Deborah Tamura; John J DiGiovanna; Kenneth H Kraemer
Journal:  Photochem Photobiol       Date:  2011-03-09       Impact factor: 3.421

8.  XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Authors:  Sikandar G Khan; Koji Yamanegi; Zhi-Ming Zheng; Jennifer Boyle; Kyoko Imoto; Kyu-Seon Oh; Carl C Baker; Engin Gozukara; Ahmet Metin; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

9.  Cutaneous malignancies in xeroderma pigmentosum: earlier management improves survival.

Authors:  Sudhir M Naik; Ashok M Shenoy; A Nanjundappa; Rajshekar Halkud; Purshottam Chavan; K Sidappa; Sumit Gupta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-01-05

10.  Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.

Authors:  Mariam B Totonchy; Deborah Tamura; Matthew S Pantell; Christopher Zalewski; Porcia T Bradford; Saumil N Merchant; Joseph Nadol; Sikandar G Khan; Raphael Schiffmann; Tyler Mark Pierson; Edythe Wiggs; Andrew J Griffith; John J DiGiovanna; Kenneth H Kraemer; Carmen C Brewer
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.